Android app Apple app link

Karyopharm Therapeutics Inc. (KPTI) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$8.68

$0.51 (6.24%)
Last update: 10:16 PM EST
Day's range
$8.11
Day's range
$8.95

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/04/2025 RBC Capital Brian Abrahams $19.00 $5.60   239.29%
10/13/2025 H.C. Wainwright Robert Burns $15.00 $5.50   172.73%
06/10/2024 RBC Capital Brian Abrahams $3.00 $0.95   215.42%

Karyopharm Therapeutics Inc. FAQ's

Karyopharm Therapeutics Inc. has been rated by research analysts at Goldman Sachs, Piper Sandler, RBC Capital, H.C. Wainwright, Robert W. Baird, Leerink Partners in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.